Abstract
Chronic fatigue syndrome (CFS) is an important condition confronting patients, clinicians, and researchers. This article provides information concerning the need for appropriate diagnosis of CFS subtypes. We first review findings suggesting that CFS is best conceptualized as a separate diagnostic entity rather than as part of a unitary model of functional somatic distress. Next, research involving the case definitions of CFS is reviewed. Findings suggest that whether a broad or more conservative case definition is employed, and whether clinic or community samples are recruited, these decisions will have a major influence in the types of patients selected. Review of further findings suggests that subtyping individuals with CFS on sociodemographic, functional disability, viral, immune, neuroendocrine, neurology, autonomic, and genetic biomarkers can provide clarification for researchers and clinicians who encounter CFS’ characteristically confusing heterogeneous symptom profiles. Treatment studies that incorporate subtypes might be particularly helpful in better understanding the pathophysiology of CFS. This review suggests that there is a need for greater diagnostic clarity, and this might be accomplished by subgroups that integrate multiple variables including those in cognitive, emotional, and biological domains.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abbey, S. E., and Garfinkel, P. E. (1991). Neurasthenia and chronic fatigue syndrome: The role of culture in the making of a diagnosis. Am. J. Psychiatry 148(12): 1638–1646.
Ablashi, D. V., Eastman, H. B., Owen, C. B., Roman, M. M., Fridman, J., Zabriskie, J. B., et al. (2000). Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J. Clin. Virol. 16(3): 179–191.
Antoni, M. H., Brickman, A., Lutgendorf, S., Klimas, N., Imia-Fins, A., Ironson, G., et al. (1994). Psychosocial correlates of illness burden in Chronic Fatigue Syndrome. Clin. Infect. Dis. 18 (Suppl 1): S73–S78.
Antoni, M. H., Fletcher, M. A., Weiss, D., Maher, K., Siegel, B. S., and Klimas, N. (2003, Feb.). Impaired Natural and Heightened Lymphocyte Activation Relate to Greater Disruptions in Patients with CFS. In: Poster presented at the Sixth International Conference on Chronic Fatigue Syndrome, Fibromyalgia, and Related Illnesses, Chantilly, VA.
Antoni, M. H., and Weiss, D. E. (2003). Stress and immunity. In Jason, L. A., Fennell, P. A., and Taylor, R. R. (eds.), Handbook of Chronic Fatigue Syndrome, Wiley, Hoboken, NJ, pp. 527–545.
Arnold, M. C., Papanicolaou, D. A., O’Grady, J. A., Lotsikas, A., Dale, J. K., Straus, S. E., et al. (2002). Using an interleukin-6 challenge to evaluate neuropsychological performance in chronic fatigue syndrome. Psychol. Med. 32: 1075–1089.
Baraniuk, J. N., Clauw, D., Yuta, A., Ali, M., Gaumond, E., Upadhyayula, N., et al. (1998). Nasal secretion analysis in allergic rhinitis, cystic fibrosis, and nonallergic fibromyalgia/chronic fatigue syndrome subjects. Am. J. Rhinol. 12: 435–440.
Barsky, A. J., and Borus, J. F. (1999) Functional somatic syndromes. Ann. Intern. Med. 130: 910–921.
Bazelmans, E., Bleijenberg, G., van der Meer, J. W. M., and Folgering, H. (2001). Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity. Psychol. Med. 31: 107–114.
Billiot, K. M., Budzynski, T. H., and Andrasik, F. (1997). EEG patterns and chronic fatigue syndrome. J. Neurother. 2(2) (available at http://www.snr-jnt.org/JournalNT/JNT(2-2)4.html)
Boas, S. R., Joswiak, M. L., Nixon, P. A., Kurland, G., O’Connor, M. J., Bufalino, K., et al. (1996). Effects of anaerobic exercise on the immune system in eight-to seventeen-year-old trained and untrained boys. J. Pediatr. 129: 846–855.
Bombardier, C. H., and Buchwald, D. (1995). Outcome and prognosis of patients with chronic fatigue and Chronic Fatigue Syndrome. Arch. Intern. Med. 155: 2105–2110.
Bombardier, C. H., and Buchwald, D. (1996). Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: Disability and health care use. Med. Care 34(9): 924–930.
Boosting Your Energy. (2002). Harvard Medical School, Boston, MA.
Borish, L., Schmaling, K., DiClementi, J., Streib, J., Negri, J., and Jones, J. F. (1998). Chronic fatigue syndrome: Identification of distinct subgroups on the basis of allergy and psychologic variables. J. Allergy Clin. Immunol. 102(2): 222–230.
Bou-Holaigah, I., Rowe, P. C., Kan, J., and Calkins, H. (1995). The relationship between neurally mediated hypotension and the Chronic Fatigue Syndrome. JAMA 274(12): 961–967.
Brimacombe, M., Zhang, Q. W., Lange, G., and Natelson, B. H. (2002–03). Immunological variables mediate cognitive dysfunction in Gulf War Veterans but not civilians with chronic fatigue syndrome. Neuroimmunomodulation 10: 93–100.
Brouwer, B., and Packer, T. (1994). Corticospinal excitability in patients diagnosed with Chronic Fatigue Syndrome. Muscle Nerve 17: 1210–1212.
Bruno, R. L. (2004). T’nts, Tips, and Techniques for Treating PPS. (http://www.postpolioinfo.com)
Buchwald, D., Herrell, R., Ashton, S., Belcourt, M., Schmaling, K., Sullivan, P., et al. (2001). A twin study of chronic fatigue. Psychosom. Med. 63: 936–943.
Buchwald, D., Pearlman, T., Kith, P., and Schmaling, K. (1994). Gender differences in patients with chronic fatigue syndrome. J. Gen. Intern. Med. 9: 387–401.
Buchwald, D., Wener, M. H., Pearlman, T., and Kith, P. (1997). Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J. Rheumatol. 24(2): 372–376.
Cairns, R., and Hotopf, M. (2005). A systematic review describing the prognosis of chronic fatigue syndrome. Occup. Med. 55: 20–31.
Cantwell, D. P. (1996). Classification of child and adolescent psychopathology. J. Child Psychol. Psychiatry 37: 3–12.
Carruthers, B. M., Jain, A. K., DeMeirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., et al. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatments protocols. J. Chronic Fatigue Syndr. 11: 7–115.
Cartmel, B., and Moon, T. (1992). Comparison of two physical activity questionnaires, with diary for assessing physical activity in an elderly population. Clin. Epidemiol. 45: 877–883.
Chaudhuri, A., and Behan, P. O. (2004). Fatigue in neurological disorders. Lancet 363: 978–988.
Chaudhuri, A., Behan, P. O., and Behan, W. M. H. (2005, Feb.). Ion Channel Function and Chronic Fatigue Syndrome. In: Paper presented at the International Conference on Fatigue Science, Karuizawa, Japan.
Chaudhuri, A., Majeed, T., Dinan, T., and Behan, P. O. (1997). Chronic Fatigue Syndrome: A disorder of central cholinergic transmission. J. Chronic Fatigue Syndr. 3: 3–16.
Ciccone, D. S., Busichio, K., Vickroy, M., and Natelson, B. H. (2003). Psychiatric morbidity in the chronic fatigue syndrome. Are patients with personality disorder more physically impaired? J. Psychosom. Res. 54: 445–452.
Clark, M. R., Katon, W., Russo, J., Kith, P., Sintay, M., and Buchwald, D. (1995). Chronic fatigue: Risk factors for symptom persistence in a two and one half year followup study. Am. J. Med. 98: 187–195.
Clauw, D. J., and Chrousos, G. P. (1997). Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4: 134–153.
Cleare, A. J. (2003, Feb.). What Psychopharmacology Tells Us About the Pathophysiology of Medically Unexplained Fatigue. In: Paper presented at the meeting towards understanding the cellular and molecular mechanisms of medically unexplained fatigue, The Brandury Center, Cold Spring Harbor Laboratory, NY.
Cleare, A. J. (2004). The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol. Metab. 15: 55–59.
Cleare, A. J., Heap, E., Malhi, G. S., Wessely, S., O’Keane, V., and Miell, J. (1999). Low-dose hydrocortisone in chronic fatigue syndrome: A randomized crossover trial. Lancet 353: 455–458.
Cleare, A. J., Messa, C., Rabiner, E. A., and Grasby, P. M. (2005). Brain 5-HT(1A) receptor binding in chronic fatigue syndrome measured using positron emission tomography and [(11)C]WAY100635. Biol. Psychiatry 57: 239–246.
Cohen, N., Moynihan, J. A., and Ader, R. (1994). Pavlovian conditioning of the immune system. Int. Arch. Allergy Immunol. 105: 101–106.
Cohen, S., Hamrick, N., Rodriguez, M. S., Feldman, P. J., Rabin, B. S., and Manuck, S. B. (2002). Reactivity and vulnerability to stress-associated risk for upper respiratory illness. Psychosom. Med. 64: 302–310.
Conti, F., Magrini, L., Priori, R., Balesini, G., and Bonini, S. (1996). Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome. Allergy 51(2): 124–127.
Cook, D. B., Lange, G., DeLuca, J., and Natelson, B. H. (2001). Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int. J. Neurosci. 107: 1–6.
Cooper, L. (2001). Report on survey of members of local ME groups. Perspectives.
Corradi, K. M., Jason, L. A., and Torres-Harding, S. (2005). Exploratory subgrouping in CFS: Infectious, inflammatory, and other. Manuscript submitted for publication.
Cukor, D., Tiersky, L., and Natelson, B. H. (2000). Psychiatric comorbidity and somatic distress in sudden and gradual onset chronic fatigue syndrome. J. Chronic Fatigue Syndr. 7(4): 33–44.
Davey, N. J., Purf, B. K., Catley, M., Main, J., Nowicky, A. V., and Zaman, R. (2003). Deficit in motor performance correlates with changed corticospinal excitability in patients with chronic fatigue syndrome. Int. J. Clin. Practice 57: 262–264.
David, A. S., Wessely, S., and Pelosi, A. J. (1991). Chronic fatigue syndrome: Signs of a new approach. Br. J. Hosp. Med. 45: 158–163.
Davis, R. (1995). Racial differences in mortality: Current trends and perspectives. In: Thomas, G. E. (ed.), Race and Ethnicity in America: Meeting the Challenge in the 21st Century, Taylor & Francis, Washington, DC, pp. 115–126.
Deale, A., Chalder, T., Marks, I., and Wessely, S. (1997). Cognitive behaviour therapy for chronic fatigue syndrome: A randomized controlled trial. Am. J. Psychiatry 154: 408–414.
Deale, A., Husain, K., Chalder, T., and Wessely, S. (2001). Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: A 5-year follow-up study. Am. J. Psychiatry 158: f2038–f2042.
Dechene, L., Friedberg, F., MacKenzie, M., and Fontanetta, R. (1994). A New Fatigue Typology for Chronic Fatigue Syndrome, Unpublished manuscript.
De Lange, F. P., Kalkman, J. S., Bleijenberg, G., Hagoort, P., vd Werf, S. P., van der Meer, J. W. M., et al. (2004). Neural correlates of the chronic fatigue syndrome—An fMRI study. Brain: 1–10 (available at http://www.cfids-cab.org/rc/de%20Lange.pdf)
DeLuca, J., Johnson, S. K., Ellis, S. P., and Natelson, B. H. (1997). Sudden versus gradual onset of chronic fatigue syndrome differentiates individuals on cognitive and psychiatric measures. J. Psychiatr. Res. 31: 83–90.
DeLuca, J., and Tiersky, L. (2003). Neurocognitive assessment. In: Jason, L. A., Fennell, P., and Taylor, R. R. (eds.), Handbook of Chronic Fatigue Syndrome, Wiley, Hoboken, NJ, pp. 417–437.
De Meirleir, K., Bisbal, C., Campine, I., De Becker, P., Salehzada, T., Demettre, E., et al. (2000). A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am. J. Med. 108: 99–105.
Demitrack, M. A. (1993). Neuroendocrine research strategies in chronic fatigue syndrome. In: Goodnick, P. J., and Klimas, N. G. (eds.), Chronic Fatigue and Related Immune Deficiency Syndromes, American Psychiatric, Washington, DC, pp. 45–66.
Dowsett, E. G., Goudsmit, E. M., Macintyre, A., and Shepherd, C. (1994). London Criteria for Myalgic Encephalomyelitis. In: Report from the National Task Force on Chronic Fatigue Syndrome (CFS), Post Viral Fatigue Syndrome (PVFS), Myalgic Encephalomyelitis (ME), Westcare, 96–98.
Dowsett, E. G., Ramsay, A. M., McCartney, R. A., and Bell, E. J. (1990). Myalgic encephalomyelitis—a persistent enteroviral infection? Postgrad. Med. J. 66: 526–530.
Edmonds, M., McGuire, H., and Price, J. (2004). Exercise therapy for chronic fatigue syndrome. Cochrane Libr. (3): 1–22.
Elenkov, I. J., Wilder, R. L., Chrousos, G. P., and Vizi, E. S. (2000). The sympathetic nerve–An integrative interface between two supersystems: The brain and the immune system. Pharmacol. Rev. 52: 595–638.
Endicott, N. A. (1999). Chronic fatigue syndrome in private practice psychiatry: Family history of physical and mental health. J. Psychosom. Res. 47: 343–354.
Euba, R., Chalder, T., Deale, A., and Wessely, S. (1996). A comparision of the characteristics of Chronic Fatigue Syndrome in primary and tertiary care. Br. J. Psychiatry 168: 121–126.
Evengard, B., Schacterle, R. S., and Komaroff, A. L. (1999). Chronic fatigue syndrome: New insights and old ignorance. J. Intern. Med. 246: 455–469.
Fennell, P. A. (1995). The four progressive stages of the CFS experience: A coping tool for patients. J. Chronic Fatigue Syndr. 1: 69–79.
Folstein, M. F., Folstein, S. E., and McHugh, P. R. (1975). Mini-mental state: A practical method for grading the state of patients for the clinician. J. Psychiatr. Res. 12: 189–198.
Friedberg, F., Dechene, L., McKenzie, M., and Fontanetta, R. (2000). Symptom patterns in long-term chronic fatigue syndrome. J. Psychosom. Res. 48: 59–68.
Friedberg, F., and Jason, L. A. (1998). Understanding Chronic Fatigue Syndrome: An Empirical Guide to Assessment and Treatment, American Psychological Association, Washington, DC.
Friedberg, F., and Krupp, L. B. (1994). A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clin. Infect. Dis. 18: S105–S110.
Friedman, S. R., Chapman, T. F., Perlis, T. E., Rockwell, R., Paone, D., Sotheran, J. L., et al. (1999). Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991–1996. J. Acquir. Immune Defic. Syndr. 22: 83–91.
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., and Komaroff, A. (1994). The Chronic Fatigue Syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 121: 953–959.
Fulcher, K. Y., and White, P. D. (1997). Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. Br. Med. J. 314: 1647–1652.
Gaab, J., Huster, D., Peisen, R., Engert, V., Heitz, V., Schad, T., et al. (2002b). Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom. Med. 64: 951–962.
Gaab, J., Huster, D., Peisen, R., Engert, V., Heitz, V., Schad, T., et al. (2003). Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects. Psychosomatics 44: 113–119.
Gaab, J., Huster, D., Peisen, R., Engert, V., Schad, T., Schurmeyer, T. H., et al. (2002a). Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom. Med. 64: 311–318.
Gellhorn, E. (1968). CNS tuning and its implications for neuropsychiatry. J. Nerv. Ment. Dis. 147: 148–162.
Gellhorn, E. (1970). The emotions and the ergotropic and trophotropic systems. Psychol. Forsch. 34: 48–94.
Gerber, L. H., and Furst, G. (1992). Validation of the NIH activity record. A quantitative measure of life activities. Arthritis Care Res. 5: 81–86.
Girdano, D. A., Everly, G. S., Jr., and Dusek, D. E. (1990). Controlling Stress and Tension. A Holistic Approach, Prentice-Hall, Englewood Cliffs, NJ.
Glaser, R., and Kiecolt-Glaser, J. K. (1998). Stress-associated immune modulation: Relevance to viral infections and chronic fatigue syndrome. Am. J. Med. 105: 35–42.
Glaser, R., Padgett, D. A., Litsky, M. L., Baiocchi, R. A., Yang, E. V., Chen, M., et al. (2005). Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: Implications for chronic fatigue syndrome and cancer. Brain Behav. Immun. 19: 91–103.
Goldstein, J. A. (1990). Chronic Fatigue Syndrome: The Struggle for Health, Chronic Fatigue Syndrome Institute, Beverly Hills, CA.
Goudsmit, E. (1996). Learning to Cope With Post-Infectious Fatigue Syndrome: A Follow-Up Study in the Psychological Aspects and Management of Chronic Fatigue Syndrome (Dissertation), Brunel Univeristy, Uxbridge, England.
Gow, J. W., Cannon, C., Behan, W. M. H., Herzyk, P., Keir, S., Riboldi-Tunnicliffe, G., et al. (2005, Feb). Whole-Genome (33,000 genes) Affymetrix DNA Microassay Analysis of Gene Expression in Chronic Fatigue Syndrome. In: Paper presented at the International Conference on Fatigue Science, Karuizawa, Japan.
Gow, J. W., Simpson, K., Behan, P. O., Chaudhuri, A., McKay, I. C., and Behan, W. M. H. (2001). Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection. Clin. Infect. Dis. 33: 2080–2081.
Grafman, J., Schwartz, V., Dale, J., Scheffers, M., Houser, C., and Strauss, S. (1993). Analysis of neuropsychological functioning in patients with chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 56(6): 684–689.
Gupta, A. (2002). Unconscious amygdalar fear conditioning in a subset of chronic fatigue syndrome patients. Med. Hypotheses 59: 727–735.
Hadzi-Pavlovic, D., Hickie, I. B., Wilson, A. J., Davenport, T. A., Lloyd, A. R., and Wakefield, D. (2000). Screening for prolonged fatigue syndromes: Validation of the SOFA scale. Soc. Psychiatry Psychiatr. Epidemiol. 35: 471–479.
Hamilton, W. T., Hall, G. H., and Pound, A. P. (2001). Frequency of attendance in general practice and symptoms before development of chronic fatigue syndrome: A case-control study. Br. J. Gen. Pract. 51: 553–558.
Hannestad, U., Theodorsson, E., and Evengard, B. (2004, Oct.). Possible Role of Beta-Alanine and Gamma-Amino Bytyric Acid (GABA) in Chronic Fatigue Syndrome. In: Paper presented at the International Conference on Chronic Fatigue Syndrome, Fibromyalgia, and other related illnesses, Madison, WI.
Hanson, S. J., Gause, W., and Natelson, B. (2001). Detection of immunologically signficant factors for chronic fatigue syndrome using neural-network classifiers. Clin. Diagn. Lab. Immunol. 8: 658–662.
Harlow, B. L., Signorello, L. B., Hall, J. E., Dailey, C., and Komaroff, A. L. (1998). Reproductive correlates of chronic fatigue syndrome. Am. J. Med. 105: 94S–99S.
Heim, C., Ehlert, U., and Hellhammer, D. H. (2000). The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25(1): 1–35.
Hickie, I., Bennett, B., Lloyd, A., Heath, A., and Martin, N. (1999a). Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: A twin study. Psychol. Med. 29: 267–277.
Hickie, I., Koschera, A., Hadzi-Pavlovic, D., Bennett, B., and Lloyd, A. (1999b) The temporal stability and co-morbidity of prolonged fatigue: A longitudinal study in primary care. Psychol. Med. 29: 855–861.
Hickie, I., Lloyd, A., Wilson, A., Hadzi-Pavlovic, D., Parker, G., Bird, K., et al. (1995). Can the Chronic Fatigue Syndrome be defined by distinct clinical features? Psychol. Med. 25: 925–935.
Hill, N. F. Tiersky, L. A., Scavalla, V. R., and Natelson, B. H. (1999). Fluctuation and outcome of chronic fatigue syndrome over time. J. Chronic Fatigue Syndr. 5(3/4): 93–94.
Hokama, Y., Whang, C., Chun, K. F., Suma, C., Higa, N., Or, B. F. W., et al. (2003). Chronic phase lipids in sera of several chronic diseases reacting with MAB CTX (antibody to ciguatoxin). J. Toxicol. 22(4): 547–554.
Holmes, G. P., Kaplan, J. E., Gantz, N. M., Komaroff, A. L., Schonberger, L. B., Strauss, S. S., et al. (1988). Chronic Fatigue Syndrome: A working case definition. Ann. Intern. Med. 108: 387–389.
Hyde, B. M., Goldstein, J. A., and Levine, P. (1992). The Clinical and Scientific Basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Nightingale Research Foundation, Ottawa, Ontario, Canada.
Jason, L. A., Fennell, P. A., Klein, S., Fricano, G., Halpert, J., and Taylor, R. R. (1999a). An investigation of the different phases of the CFS illness. J. Chronic Fatigue Syndr. 5: 35–54.
Jason, L. A., Fennell, P., and Taylor, R. R. (eds.). (2003a). Handbook of Chronic Fatigue Syndrome, Wiley, New York.
Jason, L. A., Fennell, P. A., Taylor, R. R., Fricano, G., and Halpert, J. (2000a). An empirical verification of the Fennell phases of the CFS illness. J. Chronic Fatigue Syndr. 6: 47–56.
Jason, L. A., Fricano, G., Taylor, R. R., Halpert, J., Fennell, P. A., Klein, S., et al. (2000b). Chronic fatigue syndrome: An examination of the phases. J. Clin. Psychol. 56: 1497–1508.
Jason, L. A., Helgerson, J., Torres-Harding, S. R., Carrico, A. W., and Taylor, R. R. (2003b). Variability in diagnostic criteria for chronic fatigue syndrome may result in substantial differences in patterns of symptoms and disability. Eval. Health Prof. 26: 3–22.
Jason, L. A., Jordan, K. M., Richman, J. A., Rademaker, A. W., Huang, C., McCready, W., et al. (1999b). A community-based study of prolonged and chronic fatigue. J. Health Psychol. 4: 9–26.
Jason, L. A., King, C. P., Frankenberry, E. L., Jordan, K. M., Tryon, W. W., Rademaker, F., et al. (1999c). Chronic fatigue syndrome: Assessing symptoms and activity level. J. Clin. Psychol. 55: 411–424.
Jason, L. A., King, C. P., Richman, J. A., Taylor, R. R., Torres, S. R., and Song, S. (1999d). U.S. case definition of chronic fatigue syndrome: Diagnostic and theoretical issues. J. Chronic Fatigue Syndr. 5(3/4): 3–33.
Jason, L. A., King, C. P., Taylor, R. R., and Kennedy, C. (2000c). Defining chronic fatigue syndrome: Methodological challenges. J. Chronic Fatigue Syndr. 7: 17–32.
Jason, L. A., Melrose, H., Lerman, A., Burroughs, V., Lewis, K., King, C. P., et al. (1999e). Managing chronic fatigue syndrome: A case study. AAOHN J. 47: 17–21.
Jason, L. A., Richman, J. A., Friedberg, F., Wagner, L., Taylor, R., and Jordan, K. M. (1997). Politics, science, and the emergence of a new disease: The case of Chronic Fatigue Syndrome. Am. Psychol. 52: 973–983.
Jason, L. A., Richman, J. A., Rademaker, A. W., Jordan, K. M., Plioplys, A. V., Taylor, R., et al. (1999f). A community-based study of chronic fatigue syndrome. Arch. Intern. Med. 159: 2129–2137.
Jason, L. A., and Taylor, R. R. (2002). Applying cluster analysis to define a typology of chronic fatigue syndrome in a medically-evaluated, random community sample. Psychol. Health 17: 323–337.
Jason, L. A., Taylor, R. R., and Carrico, A. W. (2001b). A community based study of seasonal variation in the onset of chronic fatigue syndrome and idiopathic chronic fatigue. Chronobiol. Int. 18: 315–319.
Jason, L. A., Taylor, R. R., and Kennedy, C. L. (2000d). Chronic fatigue syndrome, Fibromyalgia, and Multiple Chemical Sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom. Med. 62: 655–663.
Jason, L. A., Taylor, R. R., Kennedy, C. L., Jordan, K., Huang, C., Torres-Harding, S., et al. (2002a). A factor analysis of chronic fatigue symptoms in a community-based sample. Soc. Psychiatry Psychiatr. Epidemiol. 37: 183–189.
Jason, L. A., Taylor, R. R., Kennedy, C. L., Jordan, K., Song, S., Johnson, D., et al. (2000e). Chronic fatigue syndrome: Sociodemographic subtypes in a community-based sample. Eval. Health Prof. 23: 243–263.
Jason, L. A., Taylor, R. R., Kennedy, C. L., Jordan, K. M., Song, S., Johnson, D., et al. (2003c). Chronic fatigue syndrome: Symptom subtypes in a community based sample. Women Health 37: 1–13.
Jason, L. A., Taylor, R. R., Kennedy, C. L., Song, S., Johnson, D., and Torres, S. (2000f). Chronic fatigue syndrome: Occupation, medical utilization, and subtypes in a community based sample. J. Nerv. Ment. Dis. 188: 568–576.
Jason, L. A., Taylor, R. R., Kennedy, C. L., Song, S., Johnson, D., and Torres, S. (2001c). Chronic fatigue syndrome: Comorbidity with fibromyalgia and psychiatric illness. Med. Psychiatry 4: 29–34.
Jason, L. A., Taylor, R. R., Plioplys, S., Stepanek, Z., and Shlaes, J. (2002b). Evaluating attributions for an illness based upon the name: Chronic fatigue syndrome, myalgic encephalopathy, and Florence Nightingale Disease. Am. J. Community Psychol. 30: 133–148.
Jason, L. A., Taylor, R. R., Stepanek, Z., and Plioplys, S. (2001d). Attitudes regarding chronic fatigue syndrome: The importance of a name. J. Health Psychol. 6: 61–71.
Jason, L. A., Torres-Harding, S. R., Carrico, A. W., and Taylor, R. R. (2002c). Symptom occurrence with chronic fatigue syndrome. Biol. Psychol. 59: 15–27.
Jason, L. A., Torres-Harding, S. R., Jurgens, A., and Helgerson, J. (2004). Comparing the Fukuda et al. criteria and the Canadian case definition for chronic fatigue syndrome. J. Chronic Fatigue Syndr. 12: 37–52.
Jason, L. A., Torres-Harding, S. R., Taylor, R. R., and Carrico, A. W. (2001e). A comparison of the 1988 and 1994 diagnostic criteria for chronic fatigue syndrome. J. Clin. Psychol. Med. Settings 8: 337–343.
Johnson, S. K., DeLuca, J., and Natelson, B. (1999). Chronic fatigue syndrome: Reviewing the research findings. Ann. Behav. Med. 21: 258–271.
Joyce, J., Hotopf, M., and Wessely, S. (1997). The prognosis of chronic fatigue and chronic fatigue syndrome: A systematic review. Q. J. Med. 90: 223–233.
Kavelaars, A., Kuis, W., Knook, L., Sinnema, G., and Heijnen, C. J. (2000). Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 85: 692–696.
Kennedy, G., Abbot, N. C., Spence, V., Underwood, C., and Belch, J. J. F. (2004). The specificity of the CDC-1994 criteria for chronic fatigue syndrome: Comparison of health status in three groups of patients who fulfill the criteria. Ann. Epidemiol. 14: 95–100.
Kerr, J. R., Barah, F., Mattey, D. L., Laing, I., Hopkins, S. J., Hutchinson, I. V., et al. (2001). Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J. Gen. Virol. 82(12): 3011–3019.
King, C. P., and Jason, L. A. (2004). Improving the diagnostic criteria and procedures for chronic fatigue syndrome. Biol. Psychol. 68: 87–106.
King, C. P., Jason, L. A., Frankenberry, E. L., and Jordan, K. M. (1997). Think inside the envelope. CFIDS Chronicle, Fall, 10–14.
King, C. P., Jason, L. A., and Pena, J. (2004). ACTRE Variables that Differentiate Chronic Fatigue Syndrome from Depression. Manuscript submitted for publication.
Kizildere, S., Gluck, T., Zietz, B., Scholmerich, J., and Straub, R. H. (2003). During a corticotropin-releasing hormone test in healthy subjects, administration of a beta-adrenergic antagonist induced secretion of cotisol and dehydroepiandrosterone sulfate and inhibited secretion of ACTH. Eur. J. Endocrinol. 148: 45–53.
Knox, K. K., Cocchetto, A., Jordan, E., Leech, D., and Carrigan, D. R. (2004, Oct.). Deficiency in the Expression of Stat1 Protein in a Subpopulation of Patients With Chronic Fatigue Syndrome (CFS). In: Paper presented at the International Conference on Chronic Fatigue Syndrome, Fibromyalgia, and other related illnesses, Madison, WI.
Komaroff, A. L. (1988). Chronic fatigue syndromes: Relationship to chronic viral infections. J. Virol. Res. 21: 3–10.
Komaroff, A. L. (1994). Clinical presentation and evaluation of fatigue and chronic fatigue syndrome. In Straus, S. E. (ed.), Chronic Fatigue Syndrome, Marcel Dekker, New York, pp. 61–84.
Komaroff, A. L. (2000a). The biology of chronic fatigue syndrome. Am. J. Med. 108: 169–171.
Komaroff, A. L. (2000b). The physical basis of CFS. CFIDS Res. Rev. 1(2): 1–3, 11.
Komaroff, A. L., Fagioli, L. R., Geiger, A. M., Doolittle, T. H., Lee, J., Kornish, R. J., et al. (1996). An examination of the working case definition of Chronic Fatigue Syndrome. Am. J. Med. 100: 56–64.
Kroenke, K., Wood, D., Mangelsdorff, D., Meier, N., and Powell, J. (1988). Chronic fatigue in primary care: Prevalence, patient characteristics and outcome. JAMA 260: 929–934.
Landay, A. L., Jessop, C., Lennette, E. T., and Levy, J. A. (1991).Chronic fatigue syndrome: Clinical condition associated with immune activation. Lancet 338: 707–712.
Lane, R. J. M., Soteriou, B. A., Zhang, H., and Archard, L. C. (2003). Enterovirus related metabolic myopathy: A postviral fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 74: 1382–1386.
Lange, G., DeLuca, J., Maldjian, J. A., Lee, H., Tiersky, L. A., and Natelson, B. H. (1999). Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J. Neurol. Sci. 171: 3–7.
Lange, G., Wang, S., DeLuca, J., and Natelson, B. H. (1998). Neuroimaging in chronic fatigue syndrome. Am. J. Med. 105(SA): 50S–53S.
Lerner, A. M., Beqaj, S. H., Deeter, R. G., and Fitzgerald, J. T. (2002). IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2 (UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome. In Vivo 16: 153–160.
Lerner, A. M., Beqaj, S. H., Deeter, R. G., and Fitzgerald, J. T. (2004). IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with chronic fatigue syndrome. In Vivo 18: 101–106.
Levine, P. H. (1997). Epidemiologic advances in chronic fatigue syndrome. J. Psychiatr. Res. 31(1): 7–18.
Linder, R., Dinser, R., Wagner, M., Krueger, G. R. F., and Hoffmann, A. (2002). Generation of classification criteria for chronic fatigue syndrome using an artificial neural network and traditional criteria set. In Vivo 16: 37–44.
Lloyd, A. R., Hickie, I., Boughton, C. R., Spencer, O., and Wakefield, D. (1990). Prevalence of chronic fatigue syndrome in an Australian population. Med. J. Aust. 153: 522–528.
Lutgendorf, S., Klimas, N. G., Antoni, M., Brickman, A., and Fletcher, M. A. (1995). Relationships of cognitive difficulties to immune measures, depression and illness burden in Chronic Fatigue Syndrome. J. Chronic Fatigue Syndr. 1(2): 23–41.
Lyden, A., Ambrose, K., Petzke, F., Whalen, G., Stein, P., Chrousos, G., et al. (2001, Jan.). Physiologic Correlates of Chronic Fatigue Syndrome-Like Symptom Development in a Subset of Healthy Individuals Deprived of Routine Aerobic Exercise. In: Paper presented at the Annual meeting of the American Association of Chronic Fatigue Syndrome, Seattle, WA.
Maier, S. F., Watkins, L. R., and Fleshner, M. (1994). Psychoneuroimmunology. The interface between behavior, brain, and immunity. Am. Psychol. 49: 1004–1017.
Manu, P., Lane, T. J., and Matthews, D. A. (1988). The frequency of the chronic fatigue syndrome in patients with symptoms of persistent fatigue. Ann. Intern. Med. 109: 554–556.
Martinez-Lavin, M. Hermosillo, A. G., Mendoza, C., Ortiz, R., Cajigas, J. C., Pineda, C., et al. (1997). Orthostatic sympathetic derangement in subjects with fibromyalgia. J. Rheumatol. 24(4): 714–718.
Masuda, A., Mumemoto, T., Yamanake, T., Takei, M., and Tei, C. (2002a). Psychosocial characteristics and immunological functions in patients with post infectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome. J. Behav. Med. 25(5): 477–485.
Masuda, A., Nakayama, T., Yamanake, T., Koga, Y., and Tei, C. (2002b). The prognosis after multidisciplinary treatment for patients with post infectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome. J. Behav. Med. 25(5): 487–497.
McKenzie, R., O’Fallon, A., Dale, J., Demitrack, M., Sharma, G., Deloria, M., et al. (1998). Low-dose hydrocortisone for treatment of chronic fatigue syndrome. JAMA 280(12): 1061–1066.
Miller, G. E., and Cohen, S. (2001). Psychological interventions and the immune system: A meta-analytic review and critique. Health Psychol. 20: 47–63.
Miller, G. E., Cohen, S., and Ritchey, A. K. (2002). Chronic psychological stress and the regulation of pre-inflammatory cytokines: A glucocorticoid-resistance model. Health Psychol. 21: 531–541.
Minor, T. R., and Hunter, A. M. (2002). Stressor controllability and learned helplessness research in the United States: Sensitization and fatigue processes. Integr. Physiol. Behav. Sci. 37: 44–58.
Morriss, R. K., Ahmed, M., Wearden, A. J., Mullis, R., Strickland, P., Appleby, L., et al. (1999) The role of depression in pain, psychophysiological syndromes, and medically unexplained symptoms associated with chronic fatigue syndrome. J. Affect. Disord. 55: 143–148.
Moss-Morris, R., Petrie, K., Large, R., and Kydd, R. (1996). Neuropsychological deficits in chronic fatigue syndrome: Artifact or reality? J. Neurol. Neurosurg. Psychiatry 60: 474–477.
Murphy, B. E., Abbott, F. V., Allison, C. M., Watts, C., and Ghadirian, A.-M. (2004). Elevated levels of some neuroative progesterone metabolites, particularly isoprenanolone, in women with chronic fatigue syndrome. Psychoneuroendocrinology 29: 245–268.
Narita, M., Nishigami, N., Narita, N., Yamaguti, K., Okado, N., Watanabe, Y., et al. (2003). Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem. Biophys. Res. Commun. 311: 264–266.
Naschitz, J. E., Rosner, I., Rozenbaum, M., Naschitz, S., Musafia-Priselac, R., Shaviv, N., et al. (2003). The head-up tilt test with haemodynamic instability score in diagnosing chronic fatigue syndrome. Q. J. Med. 96: 133–142.
Natelson, B. H., Cheu, J., Pareja, J., Ellis, S. P., Policastro, T., and Findley, T. W. (1996). Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndome. Psychopharmacology 124: 226–230.
Natelson, B. H., Cohen, J. M., Brassloff, I., and Lee, H. J. (1993). A controlled study of brain magnetic resonance imaging in patients with fatiguing illnesses. J. Neurol. Sci. 120: 213–217.
Natelson, B. H., Weaver, S. A., Tseng, C.-L., and Ottenweller, J. E. (2005). Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin. Diagn. Lab. Immunol. 12: 52–55.
Nesher, G., Margalit, R., and Ashkenazi, Y. J. (2001). Anti-nuclear envelope antibodies: Clinical associations. Semin. Arthritis Rheum. 30(5): 313–320.
Nisenbaum, R., Jones, J. F., Unger, E. R., Reyes, M., and Reeves, W. C. (2003). A population-based study of the clinical course of chronic fatigue syndrome. Health Qual. Life Outcomes 1: 49 (Available at http://www.hqlo.com/content/1/1/49).
Nisenbaum, R., Reyes, M., Mawle, A. C., and Reeves, W. C. (1998). Factor analysis of unexplained severe fatigue and interrelated symptoms: Overlap with criteria for chronic fatigue syndrome. Am. J. Epidemiol. 148: 72–77.
Nisenbaum, R., Reyes, M., Unger, E. R., and Reeves, W. C. (2004). Factor analysis of symptoms among subjects with unexplained chronic fatigue. What can we learn about chronic fatigue syndrome? J. Psychosom. Res. 56: 171–178.
Ohashi, K., Bleijenberg, G., van der Werf, S., Prins, J., Amaral, L. A. N., Natelson, B. H., et al. (2004). Decreased fractal correlation in diurnal physical activity in chronic fatigue syndrome. Methods Inf. Med. 43: 26–29.
Paffenbarger, R., Blair, S., Lee, I., and Hyde, R. (1993). Measurement of physical activity to assess health effects in free living populations. Med. Sci. Sports Exerc. 25: 60–70.
Patarca, R. (2001). Cytokines and chronic fatigue syndrome. Ann. N.Y. Acad. Sci. 933: 185–200.
Patarca, R., Fletcher, M. A., and Klimas, N. G. (1993). Immunological correlates of chronic fatigue syndrome. In Goodnick, P. J., and Klimas, N. G. (eds.), Chronic Fatigue and Related Immune Deficiency Syndromes, American Psychiatric, Washington, DC, pp. 1–21.
Patarca-Montero, R., Mark, T., Fletcher, M. A., and Klimas, N. G. (2000). Immunology of chronic fatigue syndrome. J. Chronic Fatigue Syndr. 6: 69–107.
Pawlikowska, T., Chalder, T., Wessely, S., Wright, D., Hirsch, S., and Wallace, P. (1994). A population based study of fatigue and psychological distress. Br. Med. J. 308: 763–766.
Pazderka-Robinson, H., Morrison, J. W., and Flor-Henry, P. (2004). Electrodermal dissociation of chronic fatigue and depression: Evidence for distinct physiological mechanisms. Int. J. Psychophysiol. 53: 171–182.
Peckerman, A., Chemitiganti, R., Zhao, C., Dahl, K., Natelson, B. H., Zuckler, L., et al. (2003a). Left ventricular function in chronic fatigue syndrome (CFS): Data from nuclear ventriculography studies of responses to exercise and portural stress. FASEB 17(F Suppl: Part 2): A853.
Peckerman, A., LaManca, J. J., Dahl, K. A., Chemitiganti, R., Qureishi, B., and Natelson, B. H. (2003b). Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am. J. Med. Sci. 326(2): 55–60.
Peckerman, A., LaManca, J. J., Qureishi, B., Dahl, K. A., Golfetti, R., Yamamoto, Y., et al. (2003c). Barorecptor reflex and integrative stress response in chronic fatigue syndrome Psychosom. Med. 65: 889–895.
Perez-Stable, E. J., Marin, G., and VanOss-Marin, B. (1994). Behavioral risk factors: a comparison of Latinos and non-Latino Whites in San Francisco. Am. J. Public Health 84: 971–976.
Perkel, J. M. (2001). Distinguishing Th1 and Th2 cells: Various techniques differentiate helper T cell subsets. Scientist 15: 22–23.
Pesek, J. R., Jason, L. A., and Taylor, R. R. (2000). An empirical investigation of the envelope theory. J. Hum. Behav. Soc. Environ. 3: 59–77.
Pheley, A. M., Melby, D., Schenck, C., Mandel, J., and Peterson, P. K. (1999). Can we predict recovery in chronic fatigue syndrome? Minn. Med. 82: 52–56.
Poole, J., Herrell, R., Ashton, S., Goldberg, J., and Buchwald, D. (2000). Results of isoproterenol tilt table testing in monozygotic twins discordant for chronic fatigue syndrome. Arch. Intern. Med. 160: 3461–3468.
Powell, P., Bentall, R. P., Nye, F. J., and Edwards, R. H. T. (2001). Randomized controlled trial of patient education to encourage exercise in chronic fatigue syndrome. Br. Med. J. 322: 1–5.
Preliminary report (2001 Feb., 28). The severely affected. AFME.
Prins, J. B., Bleijenberg, G., Bazelmans, E., Elving, L. D., de Boo, T. M., Severens, J. L., et al. (2001). Cognitive behaviour therapy for chronic fatigue syndrome: A multicenter randomized controlled trial. Lancet 357: 841–847.
Ramsay, M. A. (1981). Myalgic Encephalomyelitis: A Baffling Syndrome With a Tragic Aftermath, The ME Association.
Ramsay, M. A. (1988). Myalgic Encephalomyelitis and Postviral Fatigue States: The Saga of Royal Free Disease, 2nd edn., Gower, London.
Ray, C. (1991). Chronic fatigue syndrome: Conceptual and methodological ambiguities. Psychol. Med. 21: 1–9.
Ray, C., Jeffries, S., and Weir, W. R. (1997). Coping and other predictors of outcome in chronic fatigue syndrome: a 1-year follow-up. J. Psychosom. Res. 43(4): 405–415.
Ray, C., Jeffries, S., and Weir, W. R. C. (1995). Life-events and the course of chronic fatigue syndrome. Br. J. Med. Psychol. 68: 323–331.
Regier, D. A., Boyd, J. H., Burke, J. D., Jr., Rae, D. S., Myers, J. K., Kramer, M., et al. (1988). One-month prevalence of mental disorders in the United States: Based on five Epidemiological Catchment Area sites. Arch. Gen. Psychiatry 45: 977–986.
Reeves, W. C. (2003, Feb.). Conservative Estimates of the Magnitude of Medical Unexplained Fatigue. In: Paper presented at the meeting towards understanding the cellular and molecular mechanisms of medically unexplained fatigue, The Banbury Center, Cold Spring Harbor, NY.
Reeves, W. C., Lloyd, A., Vernon, S. D., Klimas, N., Jason, L., Bleijenberg, G., et al. (2003). Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv. Res. 3: 25 (http://www.biomedcentral.com/content/pdf/1472-6963-3-25.pdf)
Reid, S., Chalder, T., Cleare, A., Hotopf, M., and Wessely, S. (2000). Extracts from “clinical evidence”: Chronic fatigue syndrome. Br. Med. J. 320: 292–296.
Reyes, M., Dobbins, J. G., Nisenbaum, R., Subedar, N., Randall, B., and Reeves, W. C. (1999). Chronic fatigue syndrome progression and self-defined recovery: Evidence from the CDC surveillance system. J. Chronic Fatigue Syndr. 5: 17–27.
Reyes, M., Nisenbaum, R., Hoaglin, D. C., Unger, E. R., Emmons, C., Randall, B., et al. (2003) Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch. Intern. Med. 163: 1530–1536.
Reynolds, K. J., Vernon, S. D., Bouchery, E., and Reeves, W. C. (2004). The economic impact of chronic fatigue syndrome. In: Cost Effectiveness and Resource Allocation. (available at http://resource-allocation.com/content/2/1/4).
Richards, R. S., Roberts, T. K., McGregor, N. R., Dunstan, R. H., and Butt, H. L. (2000). Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. Commun. Free Radic. Res. 5(1): 35–41.
Richardson, A. D., and Piepho, R. W. (2000). Effect of race on hypertension and antihypertensive therapy. Int. J. Clin. Pharmacol. Ther. 38: 75–59.
Richman, J. A., and Jason, L. A. (2001). Gender biases underlying the social construction of illness states: The case of chronic fatigue syndrome. Curr. Soc. 49: 15–29.
Robins, L., Helzer, J., Cottler, L., and Goldring, E. (1989). National Institute of Mental Health Diagnostic Interview Schedule (Version Three Rev. DIS-III-R), Department of Psychiatry, Washington University School of Medicine, St. Louis, MO.
Robins, L. N., and Regier, D. A. (1991). Psychiatric Disorders in America: The ECA Study, Free, New York.
Ruiz, P. (1995). Assessing, diagnosing, and treating culturally diverse individuals: A Hispanic perspective. Psychiatr. Q. 66: 329–341.
Saal, D., Dong, Y., Bonci, A., and Malenka, R. (2003). Drugs of abuse and stress trigger a common synaptic adaption in dopamine neurons. Neuron 37(4): 577–582.
Salit, I. E. (1997). Precipitating factors for the chronic fatigue syndrome. Journal of Psychiatr. Res. 31(1): 59–65.
Saphier, D. (1994, Oct). A Role for Interferon in the Psychoneuroendocrinology of Chronic Fatigue Syndrome. In: Paper presented at the American Association of Chronic Fatigue Syndrome Research Conference, Ft. Lauderdale, FL.
Schillings, M. L., Kalkman, J. S., van der Werf, S. P., van Engelen, B. G. M., Bleijenberg, G., and Zwarts, M. J. (2004). Diminished central activation during maximal voluntary contraction in chronic fatigue syndrome. Clin. Neurophysiol. 115: 2518–2524.
Schluederberg, A., Straus, S. E., Peterson, P., Blumenthal, S., Komaroff, A. L., Spring, S. B., et al. (1992). Chronic fatigue syndrome research: Definition and medical outcome assessment. Ann. Intern. Med. 117: 325–331.
Schmaling, K. B., Fiedelak, B. A., Katon, W. J., Bader, J. O., and Buchwald, D. S. (2003). Prospective study of the prognosis of unexplained chronic fatigue in a clinic-based cohort. Psychosom. Med. 65: 1047–1054.
Schondorf, R., and Freeman, R. C. (1999). The importance of orthostatic intolerance in chronic fatigue syndrome. Am. J. Med. Sci. 317: 117–123.
Scott, L. V., and Dinan, T. G. (1999). The neuroendocrinology of chronic fatigue syndrome: Focus on the hypothalamic-pituitary-adrenal axis. Funct. Neurol. 1(14): 3–11.
Segerstrom, S. C., and Miller, G. E. (2004). Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychol. Bull. 130: 601–630.
Sharpe, M., Hawton, K., Simkin, S., Surawy, C., Hackmann, A., Klimes, I., et al. (1996). Cognitive behaviour therapy for the chronic fatigue syndrome: A randomized controlled trial. Br. Med. J. 312: 22–26.
Sheng, W. S., Hu, S., Ding, J. M., Chao, C. C., and Peterson, P. K. (2001). Cytokine expression in the mouse brain in response to immune activation by Corynebacterium parvum. Clin. Diag. Lab. Immunol. 8(2), 446–448.
Siessmeier, T., Nix, W. A., Hardt, J., Schreckenberger, M., Egle, U. T., and Bartenstein, P. (2003). Observer independent analysis of cerebral glucose in patients with chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 74(7): 922–928.
Skowera, A., Cleare, A., Blair, D., Bevis, L., Wessely, S. C., and Peakman, M. (2004). High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin. Exp. Immunol. 135: 294–302.
Snorrason, E., Geirsson, A., and Stefansson, K. (1996). Trial of selective acetylcholinesterase inhibitor, galanthamine hydrobromide, in the treatment of Chronic Fatigue Syndrome. J. Chronic Fatigue Syndr. 2: 35–54.
Song, S., and Jason, L. A. (in press). An effort to replicate Vercoulen et al.’s model of CFS. Journal of Mental Health.
Sorensen, B., Streib, J. E., Strand, M., Make, B., Gicias, P. C., Fleshner, M., et al. (2003). Complement activation in a model of chronic fatigue syndrome. J. Allergy Clin. Immunol. 112: 397–403.
Spitzer, R., Endicott, J., and Robins, E. (1975). Clinical criteria for psychiatric diagnosis and DSM-III. Am. J. Psychiatry 132: 1187–1192.
Spitzer, R. L., Williams, J. B. W., Gibbon, M., and First, M. B. (1995). Structured Clinical Interview for DSM-IV - Non-Patient Edition (SCID-NP, Version 2.0), American Psychiatric, Washington, DC.
Sprott, H., Salemi, S., Gay, R. E., Bradley, L. A., Alarcon, G. S., Oh, S. J., et al. (2004). Increased DNA fragmentation and ultrastructural changes in fibromyalgia muscle fibers. Ann. Rheum. Dis. 63: 245–251.
Stewart, C. C., Cookfair, D. L., Hovey, K. M., Wende, K. E., Bell, D. S., and Warner, C. L. (2003). Predictive immunophenotypes: Disease-related profile in chronic fatigue syndrome. Cytometry Part B (Clin. Cytometry) 53B: 26–33.
Streeten, D. H., and Bell, D. S. (2000). The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am. J. Med. Sci. 320: 1–8.
Suhadolnik, R. J., Peterson, D. L., O’Brien, K., Cheney, P. R., Herst, C. V. T., Reichenbach, N. L., et al. (1997). Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J. Interferon Cytokine Res. 7: 377–385.
Sullivan, P. F., Smith, W., and Buchwald, D. (2002). Latent class analysis of symptoms associated with chronic fatigue syndrome and fibromyalgia. Psychol. Med. 32: 881–888.
Takahashi, L. M. (1997). Stigmatization, HIV/AIDS, and communities of color: Exploring response to human service facilities. Health Place. 3: 187–199.
Taylor, R. R., and Jason, L. A. (1998). Comparing the DIS with the SCID: Chronic fatigue syndrome and psychiatric comorbidity. Psychol. Health Int. Rev. Health Psychol. 13: 1087–1104.
Taylor, R. R., and Jason, L. A. (2001). Sexual abuse, physical abuse, chronic fatigue, and chronic fatigue syndrome: A community-based study. J. Nerv. Ment. Dis. 189: 709–715.
Taylor, R. R., Jason, L. A., and Curie, C. J. (2002). The prognosis of chronic fatigue in a community-based sample. Psychosom. Med. 64: 319–327.
Taylor, R. R., Jason, L. A., and Schoeny, M. E. (2001b). Evaluating latent variable models of functional somatic distress in a community-based sample. J. Ment. Health 10: 335–349.
Theorell, T., Blomkvist, V., Lindh, G., and Evengard, B. (1999). Psychosom. Med. 61(3): 304–310.
Tiersky, L. A., DeLuca, J., Hill, N., Dhar, S. K., Johnson, S. K., Lange, G., et al. (2001). Longitudinal assessment of neuropsychological functioning, psychiatric status, functional disability, and employment status in chronic fatigue syndrome. Appl. Neuropsychol. 8: 41–50.
Tiersky, L. A., Matheis, R. J., DeLuca, J., Lange, G., and Natelson, B. H. (2003). Functional status, neuropsychological functioning, and mood in chronic fatigue syndrome (CFS). Relationship to psychiatric disorder. J. Nerv. Ment. Dis. 191: 324–331.
Torpy, D. J., Bachmann, A. W., Gartside, M., Grice, J. E., Harris, J. M., Clifton, P., et al. (2004). Association between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SERA224 polymorphism. Endocr. Res. 30: 417–429.
Torpy, D. J., Bachmann, A. W., Grice, J. E., Fitzgerald, S. P., Phillips, P. J., Whitworth, J. A., et al. (2001). Familial corticosteroid-binding globulin deficiency due to a novel null mutation: Association with fatigue and relative hypotension. J. Clin. Endocrinol. Metab. 86: 3692–3700.
Torres-Harding, S. R., Jason, L. A., and Turkoglu, O. D. (in press). Family medical history of persons with chronic fatigue syndrome. J. Chronic Fatigue Syndr.
Torres-Harding, S. R., Jason, L. A., and Taylor, R. R. (2002). Fatigue severity, attributions, medical utilization, and symptoms in persons with chronic fatigue. J. Behav. Med. 25(2): 99–113.
Tryon, W. W., Jason, L. A., Frankenberry, E., and Torres-Harding, S. (2004). Chronic fatigue syndrome impairs circadian rhythm of activity level. Physiol. Behav. 82(5): 849–853.
Tryon, W. W., and Williams, R. (1996). Fully proportional actigraphy: A new instrument. Behav. Res. Methods Instrum. Comput. 28: 392–403.
Turk, D. C., Okifuji, A., Sinclair, J. D., and Starz, T. W. (1996). Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J. Rheumatol. 23: 1255–1262.
Turk, D. C., Okifuji, A., Sinclair, J. D., and Starz, T. W. (1998). Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res. 11: 397–404.
Van Der Linden, G., Chalder, T., Hickie, I., Koschera, A., Sham, P., and Wessely, S. (1999) Fatigue and psychiatric disorder: different or the same? Psychol. Med. 29: 863–868.
Van Hoof, E. (2004). Cognitive behavioral therapy as cure-all for CFS. J. Chronic Fatigue Syndr. 11: 43–47.
Van Houdenhove, B., Onghena, P., Neerinckx, E., and Hellin, J. (1995). Does high action-proneness make people more vulnerable to Chronic Fatigue Syndrome? A controlled psychometric study. J. Psychosom. Res. 39: 633–640.
Van Konynenburg, R. (2003a, July). Comments Posted on Nancy Klimas’ Presentation at the NIH CFS Workshop “Immune dysfunction observed in CFS.” Posted on co-cure@listserv.nodak.edu on July 2, 2003.
Van Konynenburg, R. (2003b, July). Comments Posted on Esther Sternberg’s Presentation at the NIH CFS Workshop “Health consequences of a dysregulated stress response.” Posted on co-cure@listserv.nodak.edu on July 1, 2003.
Van Konynenburg, R. (2003c, Oct.). Comments Posted on David S. Goldstein’s Presentation at the NIH CFS Workshop. Posted on co-cure@listserv.nodak.edu on November 1, 2003.
Van Konynenburg, R. (2003d). Comments Posted on Suzanne Vernon’s Presentation at the NIH CFS Workshop. Posted on co-cure@listserv.nodak.edu on June 21, 2003.
Vanness, J. M., Snell, C. R., Strayer, D. R., Dempsey, L., and Stevens, S. R. (2003). Subclassifying chronic fatigue syndrome through exercise testing. Med. Sci. Sports Exerc. 35(6): 908–913.
Van Zomeren, A., and Brouwer, W. (1994). Clinical Neuropsychology of Attention, Oxford University Press, New York.
Vercoulen, J. H., Swanink, C. M., Galama, J. M., Fennis, J. F., Jongen, P. J., Hommes, O. R., et al. (1998). The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: Development of a model. J. Psychosom. Res. 45: 507–517.
Vernon, S. D., Unger, E. R., Dimulescu, I. M., Rajeevan, M., and Reeves, W. C. (2002). Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis. Markers 18: 193–199.
Vollmer-Conna, U., Fazou, C., Cameron, B., Li, H., Brennan, C., Luck, L., et al. (2004). Production of pro-inflammatory cytokines correlates with symptoms of acute sickness behaviour in humans. Psychol. Med. 34: 1–9.
Wallace, H. L., 2nd, Natelson, B., Gause, W., and Hay, J. (1999). Human herpesviruses in chronic fatigue syndrome. Clin. Diagn. Lab. Immunol. 6(2): 216–223.
Wallman, K. E., Morton, A. R., Goodman, C., Grove, R., and Guilfoyle, A. M. (2004). Randomised controlled trial of graded exercise in chronic fatigue syndrome. Med. J. Aust. 180: 444–448.
Wearden, A., and Appleby, L. (1997). Cognitive performance and complaints of cognitive impairment in chronic fatigue syndrome. Psychol. Med. 27: 81–90.
Wearden, A. J., Morriss, R. K., Mullis, R., Strickland, P. L., Pearson, D. J., Appleby, L., et al. (1998). Randomized, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br. J. Psychiatry 172: 485–490.
van der Werf, S., Prins, J., Vercoulen, J., van der Meer, J., and Bleijenberg, G. (2000). Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J. Psychosom. Res. 49: 373–379.
Wessely, S. (1993a). The neuropsychiatry of chronic fatigue syndrome. Chronic Fatigue Syndr. 173: 212–237.
Wessely, S. (1993b). The neuropsychiatry of chronic fatigue syndrome. In Bock, B. R., and Whelan, J. (eds.), Chronic Fatigue Syndrome, Wiley, New York, pp. 212–229.
Wessely, S., Chalder, T., Hirsch, S., Pawlikowska, T., Wallace, P., and Wright, D. J. M. (1995). Postinfectious fatigue: Prospective cohort study in primary care. Lancet 345: 1333–1338.
Wessely, S., Chalder, T., Hirsch, S., Wallace, P., and Wright, D. (1996). Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: A prospective study in the primary care setting. Am. J. Psychiatry 153: 1050–1059.
Wessely, S., Chalder, T., Hirsch, S., Wallace, P., and Wright, D. (1997). The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: A prospective primary care study. Am. J. Public Health 87: 1449–1455.
Whiteside, A., Hansen, S., and Chaudhuri, A. (2004). Exercise lowers pain threshold in chronic fatigue syndrome. Pain 109: 497–499.
Whiting, P., Bagnall, A.-M., Sowden, A. J., Cornell, J. E., Mulrow, C. D., and Ramirez, G. (2001). Interventions for the treatment and management of chronic fatigue syndrome, JAMA 286: 1360–1368.
Wilson, A., Hickie, I., Hadzi-Pavlovic, D., Wakefield, D., Parker, G., Straus, S. E., et al. (2001). What is chronic fatigue syndrome: Heterogeneity within an international multicentre study. Aust. N.Z. J. Psychiatry 35: 520–527.
Wilson, A., Hickie, I., Lloyd, A., Hadzi-Pavlovic, D., Boughton, C., Dwyer, J., et al. (1994). Longitudinal study of outcome of chronic fatigue syndrome. Br. Med. J. 308: 756–759.
Wood, B., and Wessely, S. (1999). Personality and social attitudes in chronic fatigue syndrome. J. Psychosom. Res. 47: 385–397.
Wood, G., Bentall, R., Gopfert, M., Dewey, M., and Edwards, R. (1994). The differential response of chronic fatigue neurotic and muscular dystrophy patients to experimental psychological stress. Psychol. Med. 24: 357–364.
Wood, P. B. (2004). Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Med. Hypotheses 62(3): 420–424.
Yamamoto, S., Ouchi, Y., Onoe, H., Yoshikawa, E., Tsukada, H., Takahashi, H., et al. (2004). Reduction of serotonin transporters of patients with chronic fatigue syndrome. Brain Imaging 15: 2571–2574.
Yoshiuchi, K., Farkas, J., and Natelson, B. H. (2004a, May). Patients With Chronic Fatigue Syndrome Have Reduced Cerebral Blood Flow. In: Paper presented at the International Conference on Chronic Fatigue Syndrome, Fibromyalgia, and other related illnesses, Madison, WI.
Yoshiuchi, K., Quigley, K. S., Ohashi, K., Yamamoto, Y., and Natelson, B. H. (2004b). Use of time-frequency analysis to investigate temporal patterns of cardiac autonomic response during head-up tilt in chronic fatigue syndrome. Auton. Neurosci. 113: 55–62.
Zalcman, S., Savina, I., and Wise, R. A. (1999). Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats. Brain Res. 847: 276–283.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jason, L.A., Corradi, K., Torres-Harding, S. et al. Chronic Fatigue Syndrome: The Need for Subtypes. Neuropsychol Rev 15, 29–58 (2005). https://doi.org/10.1007/s11065-005-3588-2
Issue Date:
DOI: https://doi.org/10.1007/s11065-005-3588-2